Advertisement

Cancer Causes & Control

, Volume 26, Issue 7, pp 1037–1045 | Cite as

Sleep duration and cancer risk in women

  • Susan HurleyEmail author
  • Debbie Goldberg
  • Leslie Bernstein
  • Peggy Reynolds
Brief report

Abstract

Purpose

The objective was to conduct an analysis of sleep duration and risk of selected site-specific and groups of cancer among a large prospective cohort of California women.

Methods

The study population was comprised of 101,609 adult females participating in the California Teachers Study. All sites of invasive cancer prospectively diagnosed from baseline (1995–1996) through 2011 were identified through linkage to the California Cancer Registry (n = 12,322). Site-specific analyses focused on the following cancers: breast (n = 5,053), colorectal (n = 983), lung (n = 820), melanoma (n = 749), and endometrial (n = 957). Additionally, we evaluated a group of estrogen-mediated cancers consisting of breast, endometrial, and ovarian cancer (n = 6,458). Sleep duration was based on self-report of average time sleeping in the year prior to baseline. Cox proportional hazard models were used to calculate adjusted hazard ratios and 95 % confidence intervals (HRs, 95 % CI).

Results

Point estimates for all sites and site-specific cancers generally were near or below one for short sleepers (<6 h/night) and above one for long sleepers (10+ h/night); confidence intervals, however, were wide and included unity. Compared to average sleepers (7–9 h/night), long sleepers had an increased risk of the group of estrogen-mediated cancers (HR 1.22, 95 % CI 0.97–1.54, p (trend) = 0.04).

Conclusions

These analyses suggest that longer sleep may be associated with increased risks of estrogen-mediated cancers. Further studies with more refined measures of sleep duration and quality are warranted.

Keywords

Sleep duration Cancer Risk factors Circadian rhythm Prospective cohort 

Notes

Acknowledgments

This research was supported by funds provided by The Regents of the University of California, California Breast Cancer Research Program (Grant Number 16IB-0071) and National Cancer Institute Grants R01 CA77398 and K05 CA136967. The opinions, findings, and conclusions herein are those of the authors and do not necessarily represent those of The Regents of the University of California, or any of its programs. The collection of cancer incidence data used in this study was supported by the California Department of Public Health as part of the statewide cancer reporting program mandated by California Health and Safety Code Section 103885; the National Cancer Institute’s Surveillance, Epidemiology and End Results Program under contract HHSN261201000036C awarded to the Cancer Prevention Institute of California, contract HHSN261201000035C awarded to the University of Southern California, and contract HHSN261201000034C awarded to the Public Health Institute; and the Centers for Disease Control and Prevention’s National Program of Cancer Registries, under agreement #1U58 DP000807-01 awarded to the Public Health Institute. The ideas and opinions expressed herein are those of the author(s) and endorsement by the State of California Department of Public Health, the National Cancer Institute, and the Centers for Disease Control and Prevention or their Contractors and Subcontractors is not intended nor should be inferred. We express our appreciation to all the participants in the California Teachers Study and to the researchers, analysts, and staff who have contributed so much for the success of this research project. We also thank Minhthu Le for administrative support, and the California Teachers Study Steering Committee members who are responsible for the formation and maintenance of the cohort within which this study was conducted but who did not directly contribute to the current paper: Hoda Anton-Culver, Jessica Clague, Christina A. Clarke, Dennis Deapen, Pam Horn-Ross, James V. Lacey Jr, Yani Lu, Huiyan Ma, Susan L. Neuhausen, Hannah Park, Rich Pinder, Fredrick Schumacher, Sophia S. Wang, and Argyrios Ziogas.

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. 1.
    Ferrie JE, Kumari M, Salo P, Singh-Manoux A, Kivimaki M (2011) Sleep epidemiology—a rapidly growing field. Int J Epidemiol 40(6):1431–1437. doi: 10.1093/ije/dyr203 PubMedCentralPubMedCrossRefGoogle Scholar
  2. 2.
    Irwin MR (2014) Why sleep is important for health: a psychoneuroimmunology perspective. Annu Rev Psychol. doi: 10.1146/annurev-psych-010213-115205 PubMedGoogle Scholar
  3. 3.
    Institute of Medicine (2006) Sleep disorders and sleep deprivation: an unmet public health problem. The National Academies Press, WashingtonGoogle Scholar
  4. 4.
    Centers for Disease Control and Prevention Insufficient Sleep is a Public Health Epidemic. http://www.cdc.gov/features/dssleep/. Accessed 1 Oct 2014
  5. 5.
    Blask DE (2009) Melatonin, sleep disturbance and cancer risk. Sleep Med Rev 13(4):257–264PubMedCrossRefGoogle Scholar
  6. 6.
    Chandola T, Ferrie JE, Perski A, Akbaraly T, Marmot MG (2010) The effect of short sleep duration on coronary heart disease risk is greatest among those with sleep disturbance: a prospective study from the Whitehall II cohort. Sleep 33(6):739–744PubMedCentralPubMedGoogle Scholar
  7. 7.
    Heianza Y, Kato K, Fujihara K, Tanaka S, Kodama S, Hanyu O, Sato K, Sone H (2014) Role of sleep duration as a risk factor for Type 2 diabetes among adults of different ages in Japan: the Niigata Wellness Study. Diabet Med. doi: 10.1111/dme.12555 Google Scholar
  8. 8.
    Lehrer S, Green S, Ramanathan L, Rosenzweig KE (2013) Obesity and deranged sleep are independently associated with increased cancer mortality in 50 US states and the District of Columbia. Sleep Breath 17(3):1117–1118. doi: 10.1007/s11325-013-0811-x PubMedCrossRefGoogle Scholar
  9. 9.
    Lu Y, Tian N, Yin J, Shi Y, Huang Z (2013) Association between sleep duration and cancer risk: a meta-analysis of prospective cohort studies. PLoS ONE 8(9):e74723. doi: 10.1371/journal.pone.0074723 PubMedCentralPubMedCrossRefGoogle Scholar
  10. 10.
    Lucassen EA, Rother KI, Cizza G (2012) Interacting epidemics? Sleep curtailment, insulin resistance, and obesity. Ann N Y Acad Sci 1264:110–134. doi: 10.1111/j.1749-6632.2012.06655.x PubMedCentralPubMedCrossRefGoogle Scholar
  11. 11.
    Qin Y, Zhou Y, Zhang X, Wei X, He J (2014) Sleep duration and breast cancer risk: a meta-analysis of observational studies. Int J Cancer 134(5):1166–1173. doi: 10.1002/ijc.28452 PubMedCrossRefGoogle Scholar
  12. 12.
    Vgontzas AN, Liao D, Bixler EO, Chrousos GP, Vela-Bueno A (2009) Insomnia with objective short sleep duration is associated with a high risk for hypertension. Sleep 32(4):491–497PubMedCentralPubMedGoogle Scholar
  13. 13.
    Zhao H, Yin JY, Yang WS, Qin Q, Li TT, Shi Y, Deng Q, Wei S, Liu L, Wang X, Nie SF (2013) Sleep duration and cancer risk: a systematic review and meta-analysis of prospective studies. Asian Pac J Cancer Prev 14(12):7509–7515PubMedCrossRefGoogle Scholar
  14. 14.
    Carter BD, Diver WR, Hildebrand JS, Patel AV, Gapstur SM (2014) Circadian disruption and fatal ovarian cancer. Am J Prev Med 46(3 Suppl 1):S34–S41. doi: 10.1016/j.amepre.2013.10.032 PubMedCrossRefGoogle Scholar
  15. 15.
    Girschik J, Heyworth J, Fritschi L (2013) Self-reported sleep duration, sleep quality, and breast cancer risk in a population-based case–control study. Am J Epidemiol 177(4):316–327. doi: 10.1093/aje/kws422 PubMedCrossRefGoogle Scholar
  16. 16.
    Hu LY, Chen PM, Hu YW, Shen CC, Perng CL, Su TP, Yen SH, Tzeng CH, Chiou TJ, Yeh CM, Chen TJ, Wang WS, Liu CJ (2013) The risk of cancer among patients with sleep disturbance: a nationwide retrospective study in Taiwan. Ann Epidemiol 23(12):757–761PubMedCrossRefGoogle Scholar
  17. 17.
    Jiao L, Duan Z, Sangi-Haghpeykar H, Hale L, White DL, El-Serag HB (2013) Sleep duration and incidence of colorectal cancer in postmenopausal women. Br J Cancer 108(1):213–221. doi: 10.1038/bjc.2012.561 PubMedCentralPubMedCrossRefGoogle Scholar
  18. 18.
    Kakizaki M, Inoue K, Kuriyama S, Sone T, Matsuda-Ohmori K, Nakaya N, Fukudo S, Tsuji I (2008) Sleep duration and the risk of prostate cancer: the Ohsaki Cohort Study. Br J Cancer 99(1):176–178. doi: 10.1038/sj.bjc.6604425 PubMedCentralPubMedCrossRefGoogle Scholar
  19. 19.
    Kakizaki M, Kuriyama S, Sone T, Ohmori-Matsuda K, Hozawa A, Nakaya N, Fukudo S, Tsuji I (2008) Sleep duration and the risk of breast cancer: the Ohsaki Cohort Study. Br J Cancer 99(9):1502–1505. doi: 10.1038/sj.bjc.6604684 PubMedCentralPubMedCrossRefGoogle Scholar
  20. 20.
    Khawaja A, Rao S, Li L, Thompson CL (2013) Sleep duration and breast cancer phenotype. J Cancer Epidemiol 2013:467927. doi: 10.1155/2013/467927 PubMedCentralPubMedCrossRefGoogle Scholar
  21. 21.
    Luo J, Sands M, Wactawski-Wende J, Song Y, Margolis KL (2013) Sleep disturbance and incidence of thyroid cancer in postmenopausal women the Women’s Health Initiative. Am J Epidemiol 177(1):42–49. doi: 10.1093/aje/kws193 PubMedCentralPubMedCrossRefGoogle Scholar
  22. 22.
    McElroy JA, Newcomb PA, Titus-Ernstoff L, Trentham-Dietz A, Hampton JM, Egan KM (2006) Duration of sleep and breast cancer risk in a large population-based case–control study. J Sleep Res 15(3):241–249PubMedCrossRefGoogle Scholar
  23. 23.
    Pinheiro SP, Schernhammer ES, Tworoger SS, Michels KB (2006) A prospective study on habitual duration of sleep and incidence of breast cancer in a large cohort of women. Cancer Res 66(10):5521–5525PubMedCrossRefGoogle Scholar
  24. 24.
    Sturgeon SR, Luisi N, Balasubramanian R, Reeves KW (2012) Sleep duration and endometrial cancer risk. Cancer Causes Control 23(4):547–553. doi: 10.1007/s10552-012-9912-2 PubMedCrossRefGoogle Scholar
  25. 25.
    Verkasalo PK, Lillberg K, Stevens RG, Hublin C, Partinen M, Koskenvuo M, Kaprio J (2005) Sleep duration and breast cancer: a prospective cohort study. Cancer Res 65(20):9595–9600PubMedCrossRefGoogle Scholar
  26. 26.
    Vogtmann E, Levitan EB, Hale L, Shikany JM, Shah NA, Endeshaw Y, Lewis CE, Manson JE, Chlebowski RT (2013) Association between sleep and breast cancer incidence among postmenopausal women in the Women’s Health Initiative. Sleep 36(10):1437–1444. doi: 10.5665/sleep.3032 PubMedCentralPubMedGoogle Scholar
  27. 27.
    von Ruesten A, Weikert C, Fietze I, Boeing H (2012) Association of sleep duration with chronic diseases in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam study. PLoS ONE 7(1):e30972. doi: 10.1371/journal.pone.0030972 CrossRefGoogle Scholar
  28. 28.
    Weiderpass E, Sandin S, Inoue M, Shimazu T, Iwasaki M, Sasazuki S, Sawada N, Yamaji T, Tsugane S (2012) Risk factors for epithelial ovarian cancer in Japan—results from the Japan Public Health Center-based Prospective Study cohort. Int J Oncol 40(1):21–30. doi: 10.3892/ijo.2011.1194 PubMedGoogle Scholar
  29. 29.
    Wu AH, Stanczyk FZ, Wang R, Koh WP, Yuan JM, Yu MC (2013) Sleep duration, spot urinary 6-sulfatoxymelatonin levels and risk of breast cancer among Chinese women in Singapore. Int J Cancer 132(4):891–896. doi: 10.1002/ijc.27653 PubMedCentralPubMedCrossRefGoogle Scholar
  30. 30.
    Wu AH, Wang R, Koh WP, Stanczyk FZ, Lee HP, Yu MC (2008) Sleep duration, melatonin and breast cancer among Chinese women in Singapore. Carcinogenesis 29(6):1244–1248PubMedCentralPubMedCrossRefGoogle Scholar
  31. 31.
    Zhang X, Giovannucci EL, Wu K, Gao X, Hu F, Ogino S, Schernhammer ES, Fuchs CS, Redline S, Willett WC, Ma J (2013) Associations of self-reported sleep duration and snoring with colorectal cancer risk in men and women. Sleep 36(5):681–688. doi: 10.5665/sleep.2626 PubMedCentralPubMedGoogle Scholar
  32. 32.
    Henderson BE, Feigelson HS (2000) Hormonal carcinogenesis. Carcinogenesis 21(3):427–433PubMedCrossRefGoogle Scholar
  33. 33.
    Bernstein L, Allen M, Anton-Culver H, Deapen D, Horn-Ross PL, Peel D, Pinder R, Reynolds P, Sullivan-Halley J, West D, Wright W, Ziogas A, Ross RK (2002) High breast cancer incidence rates among California teachers: results from the California Teachers Study (United States). Cancer Causes Control 13(7):625–635PubMedCrossRefGoogle Scholar
  34. 34.
    California Cancer Registry. http://www.ccrcal.org/abouttheccr.html. Accessed 25 Sept 2014
  35. 35.
    Hurley S, Nelson DO, Garcia E, Gunier R, Hertz A, Reynolds P (2013) A cross-sectional analysis of light at night, neighborhood sociodemographics and urinary 6-sulfatoxymelatonin concentrations: implications for the conduct of health studies. Int J Health Geogr 12:39. doi: 10.1186/1476-072X-12-39 PubMedCentralPubMedCrossRefGoogle Scholar
  36. 36.
    Reynolds P, Hurley SE, Quach AT, Rosen H, Von Behren J, Hertz A, Smith D (2005) Regional variations in breast cancer incidence among California women, 1988–1997. Cancer Causes Control 16(2):139–150. doi: 10.1007/s10552-004-2616-5 PubMedCrossRefGoogle Scholar
  37. 37.
    Walter S, Tiemeier H (2009) Variable selection: current practice in epidemiological studies. Eur J Epidemiol 24(12):733–736. doi: 10.1007/s10654-009-9411-2 PubMedCentralPubMedCrossRefGoogle Scholar
  38. 38.
    Patel SR, Ayas NT, Malhotra MR, White DP, Schernhammer ES, Speizer FE, Stampfer MJ, Hu FB (2004) A prospective study of sleep duration and mortality risk in women. Sleep 27(3):440–444PubMedGoogle Scholar
  39. 39.
    Patel SR, Blackwell T, Ancoli-Israel S, Stone KL (2012) Sleep characteristics of self-reported long sleepers. Sleep 35(5):641–648. doi: 10.5665/sleep.1822 PubMedCentralPubMedGoogle Scholar
  40. 40.
    Stevens RG (2009) Working against our endogenous circadian clock: breast cancer and electric lighting in the modern world. Mutat Res 679(1–2):6–8Google Scholar
  41. 41.
    Ayas NT, White DP, Al-Delaimy WK, Manson JE, Stampfer MJ, Speizer FE, Patel S, Hu FB (2003) A prospective study of self-reported sleep duration and incident diabetes in women. Diabetes Care 26(2):380–384PubMedCrossRefGoogle Scholar
  42. 42.
    Nock NL, Li L, Larkin EK, Patel SR, Redline S (2009) Empirical evidence for “syndrome Z”: a hierarchical 5-factor model of the metabolic syndrome incorporating sleep disturbance measures. Sleep 32(5):615–622PubMedCentralPubMedGoogle Scholar
  43. 43.
    Patel SR, Blackwell T, Redline S, Ancoli-Israel S, Cauley JA, Hillier TA, Lewis CE, Orwoll ES, Stefanick ML, Taylor BC, Yaffe K, Stone KL (2008) The association between sleep duration and obesity in older adults. Int J Obes (Lond) 32(12):1825–1834. doi: 10.1038/ijo.2008.198 PubMedCentralCrossRefGoogle Scholar
  44. 44.
    Aeschbach D, Sher L, Postolache TT, Matthews JR, Jackson MA, Wehr TA (2003) A longer biological night in long sleepers than in short sleepers. J Clin Endocrinol Metab 88(1):26–30. doi: 10.1210/jc.2002-020827 PubMedCrossRefGoogle Scholar
  45. 45.
    Anisimov VN (2003) The role of pineal gland in breast cancer development. Crit Rev Oncol Hematol 46(3):221–234PubMedCrossRefGoogle Scholar
  46. 46.
    Reiter RJ (2004) Mechanisms of cancer inhibition by melatonin. J Pineal Res 37(3):213–214PubMedCrossRefGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2015

Authors and Affiliations

  • Susan Hurley
    • 1
    Email author
  • Debbie Goldberg
    • 1
  • Leslie Bernstein
    • 2
  • Peggy Reynolds
    • 1
    • 3
  1. 1.Cancer Prevention Institute of CaliforniaBerkeleyUSA
  2. 2.Department of Population SciencesBeckman Research InstituteDuarteUSA
  3. 3.Division of Epidemiology, Department of Health Research and PolicyStanford University School of MedicineStanfordUSA

Personalised recommendations